These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Levodopa responsive-generalized dystonic spells and moaning in DNAJC6 related Juvenile Parkinson's disease. Mittal SO Parkinsonism Relat Disord; 2020 Dec; 81():188-189. PubMed ID: 33181391 [TBL] [Abstract][Full Text] [Related]
27. Early morning dystonia in Parkinson's disease. Currie LJ; Harrison MB; Trugman JM; Bennett JP; Wooten GF Neurology; 1998 Jul; 51(1):283-5. PubMed ID: 9674823 [TBL] [Abstract][Full Text] [Related]
28. Dopa responsive dystonia and juvenile Parkinson's disease: two subtypes of the same disorder? Lamberti P; de Mari M; Iliceto G; Federico F Acta Neurol (Napoli); 1992; 14(4-6):451-4. PubMed ID: 1293988 [TBL] [Abstract][Full Text] [Related]
29. Forms of dystonia in patients with Parkinson's disease. Kidron D; Melamed E Neurology; 1987 Jun; 37(6):1009-11. PubMed ID: 3587617 [TBL] [Abstract][Full Text] [Related]
30. [Outpatient establishment and initial management of treatment with intraduodenal levodopa-carbidopa infusion in advanced Parkinson's disease]. Fernandez-Pajarin G; Ares-Pensado B; Sesar A; Iglesias-Canle J; Masa-Vazquez L; Castro A Rev Neurol; 2018 Jul; 67(1):1-5. PubMed ID: 29923594 [TBL] [Abstract][Full Text] [Related]
31. Experience with continuous enteral levodopa infusions in the treatment of 9 patients with advanced Parkinson's disease. Sage JI; Trooskin S; Sonsalla PK; Heikkila RE Neurology; 1989 Nov; 39(11 Suppl 2):60-3; discussion 72-3. PubMed ID: 2586763 [TBL] [Abstract][Full Text] [Related]
32. [Duodenale levodopa and apomorphine infusion for motor complications in advanced Parkinson's disease]. Antonini A; Jost WH Fortschr Neurol Psychiatr; 2018 Sep; 86(S 01):S5-S9. PubMed ID: 30107620 [TBL] [Abstract][Full Text] [Related]
33. Morphine in tardive and idiopathic dystonia (short communication). Berg D; Becker G; Naumann M; Reiners K J Neural Transm (Vienna); 2001; 108(8-9):1035-41. PubMed ID: 11716139 [TBL] [Abstract][Full Text] [Related]
34. Sustained enteral administration of levodopa increases and interrupted infusion decreases levodopa dose requirements. Cedarbaum JM; Silvestri M; Kutt H Neurology; 1990 Jun; 40(6):995-7. PubMed ID: 2345621 [TBL] [Abstract][Full Text] [Related]
35. Evidence for the role of spinal cord systems in Parkinson's disease-associated pain. Sage JI; Kortis HI; Sommer W Clin Neuropharmacol; 1990 Apr; 13(2):171-4. PubMed ID: 2328508 [TBL] [Abstract][Full Text] [Related]
36. [Duodenal levodopa infusion for advanced Parkinson's disease in Finland 2006-2010]. Pursiainen V; Pekkonen E Duodecim; 2012; 128(16):1707-15. PubMed ID: 23025155 [TBL] [Abstract][Full Text] [Related]
37. [Secondary effects of prolonged levodopa therapy in Parkinson's disease]. Peiró Grasa A; Grau-Veciana JM Med Clin (Barc); 1985 Jun; 85(3):88-91. PubMed ID: 4021630 [No Abstract] [Full Text] [Related]
38. Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis. Nygaard TG Adv Neurol; 1993; 60():577-85. PubMed ID: 8420194 [No Abstract] [Full Text] [Related]
40. [Management of complications related to intraduodenal infusion of levodopa/carbidopa in patients with Parkinson's disease]. Santos-Garcia D; de Deus T; Lopez-Pazos E; Macias-Arribi M; Llaneza-Gonzalez MA; Echarri-Piudo A; Carpintero P; de la Fuente-Fernandez R Rev Neurol; 2014 Jun; 58(11):505-15. PubMed ID: 24861226 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]